In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics

European Journal of Pharmacology

Volumn 325, Issue 2-3, 1997, Pages 155-164

  Idänpään Heikkilä, Juhana J ^a,c   Perrot, Serge ^b   Guilbaud, Gisèle ^c   Kayser, Valérie ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Hôpital Cochin ^*  (France)

^c INSERM   (France)

Author keywords

260; Antinociception; CCK(B); L 365; Mononeuropathic rat; Morphine; Naloxone; Receptor antagonist; Struggle latency; Vocalization threshold

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONONEUROPATHY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; VOCALIZATION;

ANALGESICS; ANIMALS; BENZODIAZEPINONES; COLD; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HEAT; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PHENYLUREA COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; SCIATIC NERVE; STRESS, MECHANICAL; VOCALIZATION, ANIMAL;

EID: 19244368994     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00123-4     Document Type: Article

References (46)

1. Ardid, D. and G. Guilbaud, 1992, Antinociceptive effects of acute and chronic injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats, Pain 49, 279.
2. Attal, N., F. Jazat, V. Kayser and G. Guilbaud, 1990, Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy, Pain 41, 235.
3. Attal, N., Y.L. Chen, V. Kayser and G. Guilbaud, 1991, Behavioral evidence that systemic morphine may modulate a phasic pain-related behavior in a rat model of peripheral mononeuropathy, Pain 47, 65.
4. Beinfeld, M.C. and M. Palkovits, 1982, Distribution of cholecystokinin (CCK) in the rat lower brain stem nuclei, Brain Res. 238, 260.
5. Beinfeld, M.C., D.K. Meyuer, R.L. Eskay, R.T. Jensen and M.J. Brownstein, 1981, The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay, Brain Res. 212, 51.
6. Bennett, G.J. and Y.K. Xie, 1988, A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain 33, 87.
7. Benoliel, J.J., E. Collin, A. Mauborgne, S. Bourgoin, J.C. Legrand, M. Hamon and F. Cesselin, 1994, Mu and delta opioid receptors mediate opposite modulation by morphine of the spinal release of cholecystokinin-like material, Brain Res. 653, 81.
8. Catheline, G., V. Kayser and G. Guilbaud, 1996, Further evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in mononeuropathic rats: involvement of kappa, but not delta, opioid receptors, Eur. J. Pharmacol. 315, 135.
9. Committee for Research and Ethical Issues of the IASP, 1983, Ethical standards for investigations of experimental pain in animals, Pain 16, 109.
10. Desmeules, J., V. Kayser and G. Guilbaud, 1993, Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain, Pain 53, 277.
11. Desmeules, J.A., V. Kayser, J. Weil-Fuggaza, A. Bertrand and G. Guilbaud, 1995, Influence of the sympathetic nervous system in the development of abnormal pain-related behaviours in a rat model of neuropathic pain, Neuroscience 67, 941.
12. Dourish, C.T., D. Hawley and S.D. Iversen, 1988, Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718, Eur. J. Pharmacol. 147, 469.
13. Dourish, C.T., M.F. O'Neill, J. Coughlan, S.J. Kitchener, D. Hawley and S.D. Iversen, 1990, The selective CCK-B antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat: evidence for mediation of CCK/opioid interactions by CCK-B receptor, Eur. J. Pharmacol. 176, 35.
14. Faris, P.L., B.R. Komisaruk, L.R. Watkins and D.J. Mayer, 1983, Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science 219, 310.
15. Frost, S.A., S.N. Raja, J.N. Campbell and R.A. Khan, 1988, Does hyperalgesia to cooling stimuli characterize patients with sympathetically-maintained pain (reflex sympathetic dystrophy)?, in: Proceedings of the Vth World Congress of Pain, eds. R. Dubner, G.F. Gebhardt and M.R. Bond (Elsevier, Amsterdam) p. 151.
16. Guilbaud, G., J.-M. Benoist, F. Jazat and M. Gautron, 1990, Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy, J. Neurophysiol. 64, 1537.
17. Itoh, S., G. Katsuura and Y. Maeda, 1982, Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat, Eur. J. Pharmacol. 80, 421.
18. Jazat, F. and G. Guilbaud, 1991, The 'tonic' pain-related behaviour seen in mononeuropathic rats is modulated by morphine and naloxone, Pain 44, 97.
19. Kayser, V. and G. Guilbaud, 1983, The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats, Brain Res. 267, 131.
20. Kayser, V., J. Desmeules and G. Guilbaud, 1995a, Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathy, Pain 60, 275.
21. Kayser, V., S.H. Lee and G. Guilbaud, 1995b, Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy, Neuroscience 64, 537.
22. Kopin, A.S., Y.-M. Lee, E.W. McBride, L.J. Miller, M. Lu, H.Y. Lin, L.F.J. Kolakowski and M. Beinborn, 1992, Expression cloning and characterization of the canine parietal cell gastrin receptor, Proc. Natl. Acad. Sci. USA 89, 3605.
23. Lee, Y.-M., M. Beinborn, E.W. McBride, M. Lu, L.F.J. Kolakowski and A.S. Kopin, 1993, The human brain cholecystokinin-B/gastrin receptor, J. Biol. Chem. 268, 8164.
24. Lee, S.H., V. Kayser, J. Desmeules and G. Guilbaud, 1994, Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats, Pain 57, 233.
25. Merskey, H., 1986, Classification of chronic pain. Descriptions of chronic pain syndromes and definition for terms. Prepared by IASP Sub-Committee on Taxonomy, Pain (Suppl. 3), S1.
26. Moran, T.H., P.M. Robinson, M.S. Goldrich and P.R. McHugh, 1986, Two brain cholecystokinin receptors: implications for behavioral actions, Brain Res. 362, 175.
27. Neil, A., V. Kayser, G. Chen, G. Guilbaud, 1990, Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy. Brain Res. 522, 140.
28. Neil, A., N. Attal and G. Guilbaud, 1991, Effects of guanethidine on sensitization to natural stimuli and self-mutilating behaviour in rats with a peripheral neuropathy, Brain Res. 565, 237.
29. Nichols, M.L., D. Bian, M.H. Ossipov, J. Lai and F. Porreca, 1995, Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats, J. Pharmacol. Exp. Ther. 275, 1339.
30. Ollat, H., 1992, Traitement pharmacologique de la douleur neuropathique, Rev. Neurol. (Paris) 148, 521.
31. O'Neill, M.F., C.T. Dourish and S.D. Iversen, 1989, Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329, Neuropharmacology 28, 243.
32. Ossipov, M., C.J. Kovelowski, T. Vanderah and F. Porreca, 1994, Naltrindole, an opioid 8 antagonist, blocks the enhancement of morphine-antinociception induced by a CCK-B antagonist in the rat, Neurosci. Lett. 181, 9.
33. Payne, R., 1986, Neuropathic pain syndromes, with special reference to causalgia and reflex sympathetic dystrophy, Clin. J. Pain 2, 59.
34. Perrot, S., N. Attal, D. Ardid and G. Guilbaud, 1993, Are mechanical and cold allodynia in mononeuropathic and arthritic rats relieved by systemic treatment with calcitonin or guanethidine?, Pain 52, 41.
35. Rattray, M., C.C. Jordan and J. De Belleroche, 1988, The novel CCK antagonist L364,718 abolishes caerulein- but potentiates morphine-induced antinociception, Eur. J. Pharmacol. 152, 163.
36. Singh, L., R.J. Oles, M.J. Field, P. Atwal, G.N. Woodruff and J.C. Hunter, 1996, Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine, Br. J. Pharmacol. 118, 1317.
37. Stanfa, L., A.H. Dickenson, X.-J. Xu and Z. Wiesenfeld-Hallin, 1994, Cholecystokinin and morphine analgesia: variations on a theme, Trends Pharmacol. Sci. 15, 65.
38. Stengaard-Pedersen, K. and L.-I. Larsson, 1981, Localization and opiate receptor binding of enkephalin, CCK and ACTH/β-endorphin in the rat central nervous system, Peptides 2 (Suppl. 1), 3.
39. Vanderhaeghen, J.-J., J.C. Signeau and W. Gepts, 1975, New peptide in the vertebrate central nervous system reacting with gastrin antibodies, Nature 257, 604.
40. Wank, S.A., R. Harkins, R.T. Jensen, H. Shapira, A. Weerth and T. Slattery, 1992, Purification, molecular cloning and functional expression of the cholecystokinin receptor from rat pancreas, Proc. Natl. Acad. Sci. USA 89, 3125.
41. Wiesenfeld-Hallin, Z., X.-J. Xu, J. Hughes, D.C. Horwell and T. Hökfelt, 1990, PD 134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes, Proc. Natl. Acad. Sci. USA 87, 7105.
42. Xu, X.-J., M.J.C. Puke, V.M.K. Verge, Z. Wiesenfeld-Hallin, J. Hughes and T. Hökfelt, 1993, Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat, Neurosci. Lett. 152, 129.
43. Xu, X.-J., J.-X. Hao, A. Seiger, J. Hughes, T. Hökfelt and Z. Wiesenfeld-Hallin, 1994, Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems, Pain 56, 271.
44. Yamamoto, T. and N. Nozaki-Tguchi, 1995, Role of cholecystokinin-B receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat, Neurosci. Lett. 202, 89.
45. B receptor antagonist L-365,260 in rat spinal cord, Eur. J. Pharmacol. 234, 147.
46. Zimmermann, M., 1979, Peripheral and central nervous mechanisms of nociception, pain and pain therapy: facts and hypotheses, in: Proceedings of the 2nd World Congress of Pain, eds. J.J. Bonica, J.C. Liebeskind and D.G. Albe-Fessard (Raven Press, New York, NY) p. 3.